Drugs / ENK Cell Infusion
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01884688 | Apr 2013 → Oct 2016 | plasma cell myeloma | University of Arkansas | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ENK Cell Infusion | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01884688 ↗ |
| Modality | Cell therapy | “autologous, ex vivo expanded-natural killer(ENK) cells” NCT01884688 ↗ |